In The News :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Dec 28, 2022

Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

Nov 16, 2022

CEO Stephan Jackman interviewed on Fox Business News

Aug 12, 2022

Alzamend Neuro aiming to rapidly develop and market safe and effective treatments for Alzheimer's

Aug 4, 2022

Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer's Data

Jul 21, 2022

FDA provides guidance to Alzamend ahead of IND application for oral therapeutic